Associate Director, Division of Clinical Cancer Genomics
Recruited to the Department of Medical Oncology in November 2021 from The Ohio State University Comprehensive Cancer Center, Heather is an internationally-recognized cancer genetic counselor and researcher with a particular emphasis on universal tumor screening of all colorectal and endometrial cancer patients for Lynch syndrome.
Senior Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research
Kathleen leads City of Hope's Intensive Course in Cancer Genetic Risk Assessment. She is a senior genetic counselor in the Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research at City of Hope.
Director, Clinical & Scientific Strategy and Medical Oncologist
Dr. Gray is associate professor and chief of the Division of Clinical Cancer Genomics within the Department of Medical Oncology & Therapeutics Research and a secondary appointment in the Department of Population Sciences.
Director, Center for Precision Medicine and Medical Oncologist
An internationally recognized cancer geneticist and oncologist, Dr. Gruber is a physician-scientist who focuses his clinical practice and research program on precision medicine and the genomics of cancer in order to improve treatment and care for cancer patients and their families.
Dr. Idos is a board-certified gastroenterologist and trained cancer geneticist, who specializes in the care of patients with Lynch syndrome, FAP (familial adenomatous polyposis) and other inherited syndromes. The goal of his research is to find new ways to prevent cancer and to improve treatment and care for cancer patients.
Dr. McDonnell specializes in medical oncology and clinical cancer genetics. Named a Top Cancer Doctor by Los Angeles Magazine, Dr. McDonnell brings more than two decades of expertise to his current role at City of Hope.
Manager, Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research
Bita Nehoray, M.S., CGC, is a licensed, board-certified genetic counselor specializing in cancer genetics. She received her master's in human genetics and genetic counseling from Stanford University. Bita joined City of Hope's Division of Clinical Cancer Genomics in 2012, where she provides cancer genetics services for patients and families suspected of having a hereditary predisposition to cancer, focusing on Li-Fraumeni syndrome and clonal hematopoiesis of indeterminate potential.
Ilana is a manager of the Precision Medicine Program and a licensed, board-certified genetic counselor specializing in cancer genetics. She received her master’s degree in genetic counseling from the Johns Hopkins/National Human Genome Research Institute. Ilana joined the City of Hope Division of Clinical Cancer Genomics in 2013, where she has provided cancer genetics services for patients and families suspected to have a hereditary predisposition to cancer. Since 2019 she has also managed and developed City of Hope’s Precision Medicine Program to provide all City of Hope patients with genomic-driven care.
She has research interests in health care communication and implementation, genetic literacy, and ELSI in genomics. She helped co-develop Helping Oncology Patients Explore (HOPE) Genomics: A patient-directed IT platform for cancer genome sequencing education and return of results. She is faculty for the City of Hope Intensive Course in Genetic Cancer Risk Assessment. She is an active member of the National Society of Genetic Counselors and Southern California Genetic Counselors.
2018-2021, Senior Genetic Counselor, Integrated Genetics, Santa Fe, NM
2018, Senior Genetic Counselor, Human Longevity, San Diego, CA
2017-2018, Genetic Counselor, Human Longevity, San Diego, CA
2014-2017, Cancer Genetic Counselor, City of Hope National Medical Center, Duarte, CA
2008-2014, Genetic Counselor, Fox Chase Cancer Center, Philadelphia, PA
2006-2008, Coordinator, Family Risk Evaluation Program and Genetic Counselor, St. Mary Medical Center, San Francisco, CA
Memberships
2006-present, National Society of Genetic Counselors
2006-present, Cancer SIG
2017-present, Precision Medicine SIG (2019-2021, Co-Chair, Elective Genome Sequencing Subcommittee)
2019-present, Prenatal SIG
2019-present, ART and Infertility SIG
Publications
Kilbride, M.K., Egleston, B.L., Hall, M.J., Patrick-Miller, L.J., Daly, M.B., Ganschow, P., Grana, G., Olopade, O.I., Fetzer, D., Brandt, A., Chambers, R., Clark, D.F., Forman, A., Gaber, R., Gulden, C., Horte, J., Long, J.M., Lucas, T., Madaan, S., Mattie, K., McKenna, D., Montgomery, S., Nielsen, S., Nielsen, S., Powers, J., Rainey, K., Rybak, C., Savage, M., Seelaus, C., Stoll, J., Stopfer, J.E., Yao, X.S., Domchek, S.M., & Bradbury, A.R. (2020). Longitudinal follow-up after telephone disclosure in the randomized COGENT study. Genet Med. 22(8)1401-1406.
Hou, Y.C., Yu, H.C., Martin, R., Cirulli, E.T., Schenker-Ahmed, N.M., Hicks, M., Cohen, I.V., Jonsson, T.J., Heister, R., Napier, L., Swisher, C.L., Dominguez, S., Tang, H., Li, W., Perkins, B.A., Barea, J., Rybak, C., Smith, E., Duchicela, K., Doney, M., Brar, P., Hernandez, N., Kirkness, E.F., Khan, A.M., Venter, J.C., Karow, D.S., & Caskey, C.T. (2020) Precision medicine integrating whole-genome sequencing, comprehensive metabolomics, and advanced imaging. Proc Natl Acad Sci USA. 117(6):3053-3062.
Solomon, I., Rybak, C., Van Tongeren, L., Kuzmich, L., Blazer, K., Nehoray, B., Niell-Swiller, M., Bray, S., Bray, T.H., Hurley, K., Weitzel, J.N., & Slavin, T.P. (2019) Experience Gained from the Development and Execution of a Multidisciplinary Multi-syndrome Hereditary Colon Cancer Family Conference. J Cancer Educ. 34(6):1204-1212.
Beri, N., Patrick-Miller, L.J., Egleston, B.L., Mall, M.J., Domchek, S.M., Daly, M.B., Ganschow, P., Grana, G., Olopade, O.I., Fetzer, D., Brandt, A., Chambers, R., Clark, D.F., Forman, A., Gaber, R., Gulden, C., Horte, J., Long, J., Lucas, T., Madaan, S., Mattie, K., McKenna, D., Montgomery, S., Nielsen, S., Powers, J., Rainey, K., Rybak, C., Savage, M., Seelaus, C., Stoll, J., Stopfer, J.E., Yao, X.S., & Bradbury, A.R. (2019) Preferences for in-person person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication of Genetic Test Results by Telephone study. Clin Genet. 95(2):293-301.
Hall, M.J., Patrick-Miller, L.J., Egleston, B.L., Domchek, S.M., Daly, M.D., Ganschow, P., Grana, G., Olopade, O.I., Fetzer, D., Brandt, A., Chambers, R., Clark, D.F., Forman, A., Gaber, Gulden, C., Horte, J., Long, J.M., Lucas, T., Madaan, S., Mattie, K., McKenna, D., Montgomery, S., Nielsen, S., Powers, J., Rainey, K., Rybak, C., Savage, M., Seelaus, C., Stoll, J., Stopfer, J.E., Yao, X.S., & Bradbury, A.R. (2018) Use and Patient-Reported Outcomes of Clinical Multigene Panel Testing for Cancer Susceptibility in the Multicenter Communication of Genetic Test Results by Telephone Study. JCO Precis. Oncol. doi:10.1200/PO.18.00199. Epub 2018 Dec. 18
Slavin, T.P., Van Tongeren, L.R., Behrendt, C.E., Solomon, I., Rybak, C., Nehoray, B., Kuzmich, L., Niell-Swiller, M., Blazer, K.R., Tao, S., Yang, K., Culver, J.O., Sand, S., Castillo, D., Herzog, J., Gray, S.W., & Weitzel, J.N. (2018) Prospective Study of Cancer Genetic variants: Variation in Rate of Reclassification by Ancestry by Ancestry. J Natl Cancer Inst. 110(10):1059-1066.
Bradbury, A.R., Patrick-Miller, L.J., Egleston, B.L., Hall, M.J., Domchek, S.M., Daly, M.B., Ganschow, P., Grana, G., Olopade, O.I., Fetzer, D., Brandt, A., Chamber, R., Clark, D.F., Forman, A., Gaber, R., Gulden, C., Horte, J., Long, J.M., Lucas, T., Madaan, S., Mattie, K., McKenna, D., Montgomery, S., Nielsen, S., Powers, J., Rainey, K., Rybak, C., Savage, M., Seelaus, C., Stoll, J., Stopfer, J.E., & Yao, X.S. (2018) Randomized Non Inferiority Trial of Telephone vs. In-Person Disclosure of Germline Cancer Genetic Test Results. JNCI 110 (9):985-993.
Weitzel, J.N., Chao, E.C., Nehoray, B., Van Tongeren, L.R., LaDuca, H., Blazer, K.R., S. Lavin, T., Pesaran, T., Rybak, C., Solomon, I. Niell-Swiller, M., Dolinsky, J.S., Castillo, D., Elliott, A., Gau, C.L., Speare, V., & Jasperson, K. (2018) Somatic TP53 variants frequently confound germ-line testing results. Genet Med. 20(8):809-816.
Slavin, T.P., Neuhausen, S.L., Nehoray, B., Niell-Swiller, M., Solomon, I., Rybak, C., Blazer, K., Adamson, A., Yang, K., Sand, S., Guerrero-Llamas, N., Castillo, D., Herzog, J., Wu, X., Tao, S., Raja, S., Chung, V., Singh, G., Nadesan, S., Brown, S., Cruz-Correa, M., Peterson, G.M., & Weitzel, J. Clinical Cancer Genomics Community Research Network (CCGCRN).(2018) The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconic anemia genes. Fam Cancer. 17(2):235-245.
Susan is a licensed, board-certified senior genetic counselor specializing in cancer genetics. She has a Master of Science degree in genetic counseling from University of California Irvine. Before completing her master’s degree, Shehayeb earned her bachelor’s degree in molecular, cell and developmental biology from University of California, Los Angeles.
Alex is a licensed board-certified genetic counselor specializing in cancer genetics at City of Hope. She received her Master of Science in Human Genetics and Genetic Counseling from Keck Graduate Institute. Before completing her master’s degree, she earned her bachelor’s degree from the University of Connecticut. She is a member of the National Society of Genetic Counselors and the Southern California Genetic Counselors. Her background in the nonprofit sector, with a focus on STEM education for underserved youth, and advocacy for healthcare equality shape her research interests. These include increasing accessibility to cancer genetics services through alternative service delivery models and expanding genomics education for patients and providers. Her graduate school research investigated providers' opinions on the importance of informed consent, barriers to pre-test counseling, and the utility of educational tools in cancer genetics.
Education
2021, Master of Science in Human Genetics and Genetic Counseling, Keck Graduate Institute, Claremont, CA
2016, Bachelor of Science in Business Management, University of Connecticut, Storrs, CT
Memberships
National Society of Genetic Counselors
Southern California Genetic Counselors
Professional Experience
2021-present, Associate Genetic Counselor, City of Hope, Duarte, CA
Anuja is a genetic counselor in the Division of Clinical Cancer Genomics at City of Hope.
Education
2019, Master of Science, genetic counseling, Brandeis University, Waltham, MA
2014, Bachelor of Science (Honors), life sciences (specialization in biomedical science), National University of Singapore, Singapore
Professional Experience
2023-present, Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
2022-2023, Associate Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
2019-2022, Cancer Genetic Counselor, Division of Clinical Genetics, Miami Cancer Institute, Baptist Health Miami Cancer Institute, Kendall, FL
2018-2019, Coordinator of Office Management, Prevention, Advocacy & Resource Center, Brandeis University Prevention Team, Brandeis University, Waltham, MA
2014-2017, Research Officer, National Heart Centre Singapore, National Heart Research Institute Singapore, Singapore
Publications
Mehta, A., Ramachandra, C.J., Singh, P., Chitre, A., Lua, C.H., Mura, M., Crotti, L., Wong, P., Schwartz, P.J., Gnecchi, M., & Shim, W., 2018. Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model. European Heart Journal, 39(16), pp.1446-1455.
Mehta, A., Ramachandra, C.J., Chitre, A., Singh, P., Lua, C.H., & Shim, W. 2017. Acetylated signal transducer and activator of transcription 3 functions as molecular adaptor independent of transcriptional activity during human cardiogenesis. Stem cells, 35(10), pp.2129-2137.
Ramachandra, C.J., Mehta, A., Lua, C.H., Chitre, A., Ja, K.M.M., & Shim, W. 2016. ErbB receptor tyrosine kinase: A molecular switch between cardiac and neuroectoderm specification in human pluripotent stem cells. Stem cells, 34(10), pp.2461-2470.
Shen, Y.J., Le Bert, N., Chitre, A.A., Koo, C.X.E., Nga, X.H., Ho, S.S., Khatoo, M., Tan, N.Y., Ishii, K.J., & Gasser, S. 2015. Genome-derived cytosolic DNA mediates type I interferon-dependent rejection of B cell lymphoma cells. Cell Reports, 11(3), pp.460-473.
Elise is a genetic counselor in the Division of Clinical Cancer Genomics at City of Hope's Duarte and Antelope Valley, California, locations. She has a Master of Science in genetic counseling and a Master of Public Health in health management and policy from the University of Michigan. Before graduate school, she earned her Bachelor of Science in Biology and German Studies from Brandeis University.
Elise joined the Clinical Cancer Genomics team in July 2020 after graduating from the University of Michigan. Her graduate research focused on understanding barriers to genetic services for cancer in underserved populations and eliciting ideas for interventions to increase uptake. In addition to access to genetic services, her special interests include alternative service delivery models, genetic testing and privacy policies, and the intersection of public health and genetic counseling.
Education
Master of Science, Genetic Counseling, 2020, University of Michigan, Ann Arbor, MI
Master of Public Health (Health Management and Policy), 2020, University of Michigan, Ann Arbor, MI
Bachelor of Science, Biology and German studies, magna cum laude, 2015, Brandeis University, Waltham, MA
Professional Experience
2023-present, Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
2020-2023, Associate Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
2018-2020, Student Administrative Assistant, Department of Pediatric Genetics, University of Michigan, Ann Arbor, MI
2016-2017, Patient Care Coordinator, Planned Parenthood of the Great Northwest and Hawaiian Islands, Bellevue, WA
Elyssa is a licensed, board-certified genetic counselor specializing in cancer genetics. She has a Master of Science in genetic counseling from the University of California, Irvine, and a bachelor’s degree from the University of California, Los Angeles, with a minor in Italian. Zukin joined City of Hope in 2020 as part of the Center for Precision Medicine. Her past research investigated clinical care implications for patients with genetic variants in genes associated with hereditary cancer syndromes that have conflicting interpretations by different genetics laboratories. She is also a member of the National Society of Genetic Counselors and the Southern California Genetic Counselors.
Education
2020, Master of Science in Genetic Counseling, University of California, Irvine
2017, Bachelor of Science in Biology, Minor in Italian, University of California, Los Angeles
Professional Experience
2023-present, Genetic Counselor, Center for Precision Medicine, City of Hope, Duarte, CA
2020-2023, Associate Genetic Counselor, Center for Precision Medicine, City of Hope, Duarte, CA
2019-2020, Pediatric/NICU Genetic Counseling Assistant, Children’s Hospital of Orange County, University of California, Irvine
2017-2018, Research Consent Specialist, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA
Publications
Zukin, E., Culver, J. O., Liu, Y., Yang, Y., Ricker, C. N., Hodan, R., Sturgeon, D., Kingham, K., Chun, N. M., Rowe-Teeter, C., Singh, K., Zell, J. A., Ladabaum, U., McDonnell, K. J., Ford, J. M., Parmigiani, G., Braun, D., Kurian, A. W., Gruber, S. B., & Idos, G. E. (2023). Clinical implications of conflicting variant interpretations in the cancer genetics clinic. Genetics in medicine: official journal of the American College of Medical Genetics, 25(7), 100837. https://doi.org/10.1016/j.gim.2023.100837
Zhang, K., Liu, J., Truong, T., Zukin, E., Chen, W., & Saxon, A. (2017). Blocking allergic reaction through targeting surface-bound IgE with low-affinity anti-IgE antibodies. The Journal of Immunology, 198(10), 3823-3834.
Hunaydah is an associate genetic counselor in the Division of Clinical Cancer Genomics at City of Hope.
Education
2021, Master of Science, Genetic Counseling, University of Cincinnati, Cincinnati Children’s Hospital, Cincinnati, OH
2018, Bachelor of Science (Honors), Biomedical Science with CO-OP magna cum laude, University of Ottawa, Ottawa, Canada
Professional Experience
2021-present, Associate Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
Publications
Elfarawi, H., Tolusso, L., McGowan, M.L., Cortezzo, D., & Vawter-Lee, M. Alobar holoprosencephaly: Exploring mothers' perspectives on prenatal decision-making and prognostication. Prenat Diagn. 2022 May;42(5):617-627.
Elfarawi, H., Tolusso, L., McGowan, M., Cortezzo, D.M., & Vawter-Lee, M. Alobar holoprosencephaly: Parental perspectives on prenatal decision-making, prenatal provider prognostication, and quality of life [Abstract 116]. International Society of Prenatal Diagnosis, 2021.
Marshall, S., Bayley, M., McCullagh, S., Berrigan, L., Fischer, L., Ouchterlony, D., Rockwell, C., Velikonja, D., et al. Guideline for Concussion/Mild Traumatic Brain Injury and Prolonged Symptoms: 3rd Edition (for Adults 18+ years of age). Ontario Neurotrauma Foundation, 2018.
Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research
Kathryn is a genetic counselor in the Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, at City of Hope.
Education
2020, Master of Science, Human Genetics and Genetic Counseling, Stanford University
2017, Bachelor of Science, Biological Sciences, University of California, Irvine
Professional Experience
2022-present, Genetic Counselor, City of Hope National Medical Center, Duarte, CA
2020-2022, Cancer Genetic Counselor, Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA
2017-2018, Genetic Counselor Assistant, Patty and George Hoag Cancer Center, Newport Beach, CA
Publications
Reyes, K.G., Clark, C., Gerhart, M., Newson, A.J., & Ormond, K.E. “‘I wish that there was more info’: Characterizing the uncertainty experienced by carriers of pathogenic ATM and/or CHEK2 variants.” Familial Cancer (2021). https://doi.org/10.1007/s10689-021-00251-3
Clark, C.R., Reyes, K., Ormond, K.E., Caleshu, C., & Moscarello, T. “U.S. Genetic counselors’ perceptions of inpatient genetic counseling: A valuable model for medically complex patients.” Journal of Genetic Counseling (2021). https://doi.org/10.1002/jgc4.1435
Reyes, K.G. “Physical Activity and Body Composition in Toddlers with Neurodevelopmental Disorders.” Francisco J. Ayala School of Biological Sciences Journal of Undergraduate Research (2015).
Michael is a genetic counselor in the Division of Clinical Cancer Genomics at City of Hope.
Master of Science, Genetic Counseling, 2021, University of Michigan, Ann Arbor, MI
Bachelor of Arts, Integrative Biology, 2011, University of California Berkeley, Berkeley, CA
Professional Experience
2021-present, Associate Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
2020-2021, Project Consultant, Mainstream Genomics, San Mateo, CA
2018-2019, Genetic Counselor Assistant, University of California San Francisco (UCSF) Cancer Genetics and Prevention Program, San Francisco, CA
2016-2017, Clinical Research Coordinator, COTES Study UCSF Department of Psychiatry, San Francisco, CA
2012-2016, Staff Research Associate II, UCSF NRG Oncology Biospecimen Bank, San Francisco, CA
Publications
Restrepo, M.L. (2021, September). Exploring Perspectives in a Diverse Patient Cohort on the Duty to Recontact with Updates to Variants of Uncertain Significance [Poster Presentation]. National Society of Genetic Counselors Annual Conference.
Restrepo, M.L. (2021, April). The Responsibility to Recontact After Reporting VUS Results: Exploring Diverse Patient Perspectives on How to Stay Updated on Genetic Information [Thesis Presentation]. Department of Human Genetics Seminar, University of Michigan.
Ashley is an associate genetic counselor in the Division of Clinical Cancer Genomics at City of Hope.
Education
Master of Science, Genetic Counseling, 2022, Northwestern University, Chicago, IL
Bachelor of Science, Molecular, Cell and Developmental Biology, Dean’s Honors List, 2018, University of California Los Angeles, Los Angeles, CA
Professional Experience
2022-present, Associate Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
Associate Genetic Counselor, Duarte and South Pasadena, CA
Kaila is an associate genetic counselor in the Division of Clinical Cancer Genomics at City of Hope in Duarte and South Pasadena, California.
Education
Master of Science, Human Genetics and Genetic Counseling, 2022, Keck Graduate Institute, Claremont, CA
Bachelor of Arts, Psychology (with distinction), Gold LEAD Medallion Scholar, 2020, University of Windsor, Windsor, ON
Bachelor of Science, Biology (Honors), Gold LEAD Medallion Scholar, 2019, University of Windsor, Windsor, ON
Professional Experience
2022-present, Associate Genetic Counselor, Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
Publications
Senecal, J.B., Metcalfe, K., Wilson, K., Woldie, I., & Porter, L.A. (2021). Barriers to Translational Research in Windsor Ontario: a Survey of Clinical Care Providers and Health Researchers. Journal of Translational Medicine, 19(1). https://doi.org/10.1186/s12967-021-03097-6
Eichhorn, S.H., El-Ballouli, A.O., Cassar, A., & Kaafarani, B.R. (2021). Columnar mesomorphism of board-shaped Perylene, Diketopyrrolopyrrole, Isoindigo, Indigo, and Quinoxalino-Phenanthrophenazine Dyes. Chempluschem, 86(2), 319–339. https://doi.org/10.1002/cplu.202100024 (Graphical Abstract)
Pignanelli, J., Billet, B., Straeten, M., Prado, M., Schlingman, K., Ahamed, M.J., & Rondeau-Gagné, S. (2019). Imine and Metal–Ligand Dynamic Bonds in Soft Polymers for Autonomous Self-healing Capacitive-Based Pressure Sensors. Soft Matter, 15, 7654–7662. doi: 10.1039/c9sm01254k (Graphical Abstract)
Brittany leads a nurse-practitioner-run breast cancer survivorship program at City of Hope with over 1,000 patients under her care. She recently completed the City of Hope's Clinical Cancer Genetics program. She currently works in the high-risk screening and prevention clinic.
Education
2021-2022, Clinical Cancer Genetics Intensive Course, City of Hope, Duarte, CA
2018, Chemotherapy Certification Course, City of Hope, Duarte, CA
2010-2012, Master of Science, Nursing, Gerontology Acute-Care Nurse Practitioner, University of California, Los Angeles
2001-2005, Bachelor of Science, Nursing, University of Manitoba, Winnipeg, Manitoba
Professional Experience
2021-present, High-Risk Screening and Prevention Nurse Practitioner, City of Hope, Duarte, CA
2016-present, Breast Cancer Nurse Practitioner, City of Hope, Duarte, CA
2012-2016, Medical Oncology and Hematology Nurse Practitioner, City of Hope, West Covina and Glendora, CA
Publications
Bradford, B. (2012). Chemotherapy-induced infertility in patients with testicular cancer. Oncology Nursing Forum, 39(1):27-39.
